GLAXO OPERATIONS UK, Limited ,   United Kingdom

Glucocorticosteroid for topical application
Spray nasal dosed with 27.5 μg / dose.
Antimicrobial agent
Ointment for external use, 1%.
Adrenomimetics in combination with anticholinergics.

Powder for inhalation dosed, 22 mcg + 55 mcg / dose.

Monoclonal antibodies.
Concentrate for solution for infusion, 20 mg / ml.
Antitumor agent. Antimetabolite

Solution for infusions 5 mg / ml.

Antibiotic

Ointment for external use, 2%.

Antibiotic for topical use

Nasal ointment, 2%.

Antitumor agent - protein tyrosine kinase inhibitor

The film-coated tablets are 200 mg and 400 mg.

An antiviral agent.
Tablets, film-coated, 100 mg.
antiviral [HIV] agent

Film-coated tablets, 300 mg.

Antibiotic-cephalosporin
Granules for oral suspension, 125 mg / 5 ml.
Antibiotic-cephalosporin
Tablets, film-coated, 125 mg, 250 mg.
Antiviral for topical use
Eye ointment 3%.
Acne rash remedy
Gel for external use, 50 mg + 10 mg / 1 g of gel.
Antiaggregant agent

Solution for intravenous administration 0.75 mg / ml, 2 mg / ml.

Antiviral [HIV] agent
Film-coated tablets, 600 mg + 300 mg.
Antiviral (HIV) agent
Tablets, film-coated, 300 mg + 150 mg.

antiepileptic agent

Tablets, 25 mg, 50 mg and 100 mg.

hemopoiesis stimulant

Film-coated tablets, 25 mg and 50 mg.

Bronchodilator combined (beta2-adrenomimetic selective + glucocorticosteroid local).

Powder for inhalation dosed, 22 mcg + 92 mcg / dose, 22 mcg + 184 mcg / dose.

An antiviral [HIV] agent.

Solution for infusions 10 mg / ml.

Bronchodilator (beta2-adrenomimetic selective + glucocorticosteroid local).
The powder for inhalation is dosed, 50 μg + 100 μg / dose, 50 μg + 250 μg / dose, 50 μg + 500 μg / dose.
Antitumor agent, protein kinase inhibitor

A set of capsules and film-coated tablets, 50 mg and 0.5 mg, 50 mg and 2.0 mg, 75 mg and 0.5 mg, 75 mg and 2.0 mg.

Antiviral (HIV) agent, protease inhibitor (PI).

The tablets covered with a cover, 700 mg.

antiviral [HIV] agent

Tablets, film-coated, 50 mg.

Antiviral [HIV] agent
The tablets covered with a film cover, 300 mg + 150 mg + 300 mg.
Antiviral [HIV] agent
Film-coated tablets, 300 mg.